Stay updated with breaking news from Joseph Stringer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biotech stocks make for an interesting study. They represent a high-risk sector, characterized by famously high overhead and long lead times to develop new products. However, they also hold the potential for high rewards when new drugs open up markets with potential sales targets sometimes reaching billions of dollars. It’s not just the future sales potential that fuels the possibilities for rewards; a successful small-cap biotech company, with a newly approved drug, will frequently attract merg
Operator: Good morning, and welcome to Ionis First Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded.
Operator: Good afternoon. My name is Josh, and I will be your conference facilitator.
MRNA earnings call for the period ending December 31, 2022.